Narrow Dental Implants in Multiple Fixed Prosthesis: A Controlled Clinical Trial

Exclusion Criteria

• •Presence of an active infection
• •Being under active treatment with, or have received in the las 30 days treatment with radiotherapy, chemotherapy, immunosuppressors, systemic corticosteroids and/or anticoagulants.
• •Presence of severe haematologic disorders.
• •Chronic treatment with non steroidal anti-inflammatory drugs (NSAID) or other aniinflammatory drugs.
• •Previous diagnosis of chronic hepatitis or liver cirrhosis.
• •Presence of Diabetes mellitus with improper metabolic control (glycosylated haemoglobine higher that 9%).
• •Patients subjected to dialysis.
• •Presence of malignant tumours, haemangioma or angioma in the surgical area.
• •History of ischaemic cardiopathy in the las year.
• •Pregnancy or plan to getting pregnant during the study.
• •Metabolic bone disease
• •Patientd receiving treatment with oral or intravenous biphosphonates.
• •Any other condition incompatible with the participation in the study,